At the present time there is no means of directly identifying activated chondrocytes within the cartilage, or of determining whether particular indigenous chondrocytes are more susceptible to the cytokine, or indeed whether there are differences in cytokine activation of chondrocytes in different regions of the cartilage. The immunocytochemical detection of the surface epitopes described in this study is believed to be the first identification of individual IL-1 activated chondrocytes within articular cartilage.
Since the first observation that cytokine messengers derived from synovial tissue were able to degrade cartilage matrix and prevent its repair' intense interest has centred on the nature of the cytokine/cartilage interactions. The principal cytokines controlling articular cartilage matrix turnover are now known to be interleukin-la (IL-la) and IL-1,B and possibly tumour necrosis factor,2 3 though the second messenger involved has not yet been elucidated.
Reports' suggest that monolayer cultured chondrocytes stimulated with IL-1 release a variety of enzymes, including latent metalloproteinases, which, upon in situ activation, would be capable of degrading both collagen and proteoglycan.7 8 Such studies indicate that chondrocyte activation by IL-1 may play a part in the control of the dynamic equilibrium between synthesis and degradation in cartilage matrix. Therefore, the immunological detection ofsuch enzymes would provide a useful indicator of cytokine induced chondrocyte activation and a direct means of attributing local sites of matrix degradation to enzyme secretion by individual cells. Despite numerous attempts, however, it has been impossible to immunolocalise these enzymes in IL-I treated adult cartilage (Hembry R M, personal communication and unpublished PhD thesis), in contrast with observations on chondrocytes in monolayer cultures or postfetal cartilage in culture. Hence the enzymes cannot be used as a marker for chondrocyte activation in cytokine mediated cartilage damage in adult tissue.
At the present time there is no means of directly identifying activated chondrocytes within the cartilage, or of determining whether particular indigenous chondrocytes are more susceptible to the cytokine, or indeed whether there are differences in cytokine activation of chondrocytes in different regions of the cartilage. The immunocytochemical detection of the surface epitopes described in this study is believed to be the first identification of individual IL-1 activated chondrocytes within articular cartilage.
Materials and methods

TREATMENT OF CARTILAGE IN CULTURE WITH IL-la
Cartilage was obtained by dissection from the chondylar ridge of the metacarpophalangeal joints of 6-9 month old pigs. Paired explants of tissue were taken from the joint for comparative histological and biochemical studies and were cultured in 0-5 ml of medium (Dulbecco's minimum essential medium; Gibco) containing 120 tg/ml benzylpenicillin and 200 ,ug/ml streptomycin supplemented with 5% heat inactivated fetal calf serum. The cultures were set up in 25-well plastic dishes (Sterilin) and maintained at 37°C in a 5% CO2 environment. Pig IL-la, purified as described by Saklatvala et Sections which had been incubated with the unadsorbed antiserum at dilutions down to 1:5000 showed intense membrane staining in most cells in all regions of both untreated and IL-1 treated cartilage. Diffuse staining of the matrix was also seen spreading across the articular surface into the mid-zone. Maximum fluorescence was observed in sections from cartilage which had been exposed to IL-1 for four days. After only one day of IL-I treatment higher concentrations of antiserum (1:2000) showed weak matrix staining and membrane staining in a few cells in the articular surface. Immunoreactive chondrocytes were found in all regions of the cartilage from the articular surface, through the mid-zone to the hypertrophic zone. It is abundantly clear, however, that not all cells were positive (fig A) , and a more detailed time-course study is currently in progress to assess the proportion of unreactive cells within the different zones. A similar distribution of membrane stained chondrocytes was seen in cartilage which had been treated with human recombinant IL-la for four days, using the adsorbed antiserum at dilutions of 1:100 or 1: 250 (fig B) .
The specificity of the antiserum was confirmed by the absence ofmembrane fluorescence when PBS or preimmune serum ( fig C) 
Discussion
In the work reported in this paper we set out to determine whether it was possible to identify indigenous cartilage chondrocytes that had been activated by IL-1. Although the two principal actions on cartilage-namely, the increased catabolism of the extracellular matrix molecules and the inhibition of proteoglycan synthesis, have been well reported in many animal and human cartilages, there has been no report of any method which identifies whether these effects are due to all the cells in the cartilage or to cells at specific sites or, indeed, to individual cells in a particular area. We report here the recognition of individual IL-1 activated chondrocytes in situ using an antiserum which had been raised against IL-1 stimulated pig chondrocytes and subsequently exhaustively adsorbed with normal, untreated pig chondrocytes. The specific immunoreactivity of the adsorbed antiserum was confirmed by recognition of IL-I induced surface epitopes on indigenous chondrocytes in IL-I treated explants, whereas chondrocytes in cartilage which had not been exposed to the cytokine showed no evidence of activation. We thank Dawn Ward and Margaret Flack for excellent technical assistance. The human recombinant interleukin-la was a gift from Ciba-Geigy.
